Examples of 'bazedoxifene' in a sentence
Meaning of "bazedoxifene"
Bazedoxifene is a medication used for the treatment of osteoporosis in postmenopausal women
Show more definitions
- A SERM medication used to treat bone problems.
How to use "bazedoxifene" in a sentence
Basic
Advanced
bazedoxifene
Bazedoxifene has not been studied in premenopausal women.
It is not known whether bazedoxifene is excreted in human milk.
Bazedoxifene is used in the treatment of postmenopausal osteoporosis.
Negligible amounts of bazedoxifene were eliminated in urine.
Bazedoxifene is also used in the prevention of postmenopausal osteoporosis.
There is no relevant use of bazedoxifene in the paediatric population.
The active substances are conjugated oestrogens and bazedoxifene.
Bazedoxifene is extensively metabolised in women.
New polymorphic form of bazedoxifene acetate.
Bazedoxifene has the same effect as oestrogen in the bone.
Adverse reactions that have been observed with bazedoxifene monotherapy.
The pharmacokinetics of bazedoxifene have not been studied in the paediatric population.
Impaired renal function showed little or no influence on bazedoxifene pharmacokinetics.
Bazedoxifene active coating.
Conbriza is a medicine that contains the active substance bazedoxifene.
See also
A reduction in bazedoxifene exposure may be associated with an increased risk of endometrial hyperplasia.
There are no data from the use of bazedoxifene in pregnant women.
The following data are based on the findings in studies with bazedoxifene.
Bazedoxifene belongs to a class of compounds known as selective estrogen receptor modulators SERMs.
The active substance is bazedoxifene.
Bazedoxifene is used as treatment for osteoporosis in postmenopausal women at increased risk of fracture.
The synthetic preparation of bazedoxifene acetate has also appeared in the general literature.
Bazedoxifene decreases bone resorption and reduces biochemical markers of bone turnover to the premenopausal range.
Paediatric population There is no relevant use of bazedoxifene in the paediatric population.
The bazedoxifene solid dispersion blend was prepared by direct blending using a mortar and pestle.
Paediatric population The pharmacokinetics of bazedoxifene have not been studied in the paediatric population.
Bazedoxifene can be mixed into a suitable coating suspension and applied using conventional spray methods.
DUAVIVE is a medicine that contains two active substances called conjugated oestrogens and bazedoxifene.
The effect of bazedoxifene on BMD at other skeletal sites was similar.
Method of preparing polymorphic pure form A of bazedoxifene acetate.
Polymorphic forms of Bazedoxifene x acetate are disclosed in the prior art.
In a further embodiment, a pharmaceutically acceptable salt of bazedoxifene is used.
Bazedoxifene does not induce or inhibit the activities of major CYP isoenzymes.
The absolute bioavailability of bazedoxifene is approximately 6.
Any form of Bazedoxifene x acetate may be applied in step a of the above process.
Duavive conjugated oestrogens / bazedoxifene.
Bazedoxifene was developed by Pfizer following the completion of their takeover of Wyeth Pharmaceuticals.
In yet another embodiment, the bazedoxifene formulation contains, bazedoxifene acetate.
Duavive contains two active substances, conjugated oestrogens and bazedoxifene.
Therefore, bazedoxifene is not recommended for treatment or prevention of breast cancer.
Importantly, in both species, the administration of bazedoxifene had no deleterious effects on bone quality.
Bazedoxifene functions primarily as an oestrogen-receptor antagonist in uterine and breast tissues.
In yet another embodiment, the bazedoxifene is a coating applied to the multiparticulates.
Bazedoxifene belongs to a group of non-hormonal medicines called selective estrogen receptor modulators SERMs.
Do not take other estrogens, a progestin, or other drugs like bazedoxifene while taking this drug.
In this cell type, bazedoxifene also potently inhibited cell growth.
In yet another embodiment, the bazedoxifene is BZA.
Other SERMs, such as bazedoxifene and lasofoxifene, are in the late stages of clinical development.
Adverse reactions reported with CE and / or bazedoxifene monotherapy.
Still other bazedoxifene granulations or solid dispersion blends, or other formulations can be utilized.
